0001209191-23-021260.txt : 20230327 0001209191-23-021260.hdr.sgml : 20230327 20230327172843 ACCESSION NUMBER: 0001209191-23-021260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230323 FILED AS OF DATE: 20230327 DATE AS OF CHANGE: 20230327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calabrese Salvatore CENTRAL INDEX KEY: 0001851958 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40237 FILM NUMBER: 23765539 MAIL ADDRESS: STREET 1: C/O GAIN THERAPEUTICS, INC. STREET 2: 4800 HAMPDEN LANE, SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-23 0 0001819411 Gain Therapeutics, Inc. GANX 0001851958 Calabrese Salvatore C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814 0 1 0 0 Chief Financial Officer 0 Employee Stock Option (right to buy) 4.84 2023-03-23 4 A 0 50000 0.00 A 2033-03-23 Common Stock 50000 50000 D Restricted Stock Units 2023-03-23 4 A 0 25000 0.00 A Common Stock 25000 25000 D The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. /s/ Jason Minio, Attorney-in-Fact 2023-03-27